Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma

Annals of Thoracic Surgery

Volumn 93, Issue 5, 2012, Pages 1682-1688

  Luo, Kong Jia ^a,b   Wen, Jing ^a,b   Xie, Xuan ^a,b   Fu, Jian Hua ^a,b   Luo, Rong Zhen ^a,b   Wu, Qiu Liang ^a,b   Hu, Yi ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; DISEASE SPECIFIC SURVIVAL; DNA BINDING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THORACOTOMY; TISSUE MICROARRAY;

EID: 84860255768     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.01.102     Document Type: Article

References (37)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
3. A. Jemal, R. Siegel, J. Xu, E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
4. T.W. Rice, E.H. Blackstone, V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
5. P.K. Hsu, Y.C. Wu, T.Y. Chou, C.S. Huang, W.H. Hsu Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma Ann Thorac Surg 89 2010 1024 1031
6. R. Benezra, R.L. Davis, D. Lockshon, D.L. Turner, H. Weintraub The protein Id: a negative regulator of helix-loop-helix DNA binding proteins Cell 61 1990 49 59
7. R. Benezra, S. Rafii, D. Lyden The Id proteins and angiogenesis Oncogene 20 2001 8334 8341 (Pubitemid 34121904)
8. Z. Zebedee, E. Hara Id proteins in cell cycle control and cellular senescence Oncogene 20 2001 8317 8325 (Pubitemid 34121902)
9. H.A. Sikder, M.K. Devlin, S. Dunlap, B. Ryu, R.M. Alani Id proteins in cell growth and tumorigenesis Cancer Cell 3 2003 525 530 (Pubitemid 36808647)
10. Y.C. Wong, X. Wang, M.T. Ling Id-1 expression and cell survival Apoptosis 9 2004 279 289 (Pubitemid 38981502)
11. M. Schindl, G. Oberhuber, A. Obermair, S.F. Schoppmann, B. Karner, P. Birner Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer Cancer Res 61 2001 5703 5706 (Pubitemid 32769080)
12. S.F. Schoppmann, M. Schindl, G. Bayer Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer Int J Cancer 104 2003 677 682 (Pubitemid 36418503)
13. J.P. Coppe, Y. Itahana, D.H. Moore, J.L. Bennington, P.Y. Desprez Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression Clin Cancer Res 10 2004 2044 2051 (Pubitemid 38375565)
14. K.T. Lee, Y.W. Lee, J.K. Lee Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers Br J Cancer 90 2004 1198 1203 (Pubitemid 38496813)
15. Y.C. Hu, K.Y. Lam, S. Law, J. Wong, G. Srivastava Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC Clin Cancer Res 7 2001 2213 2221 (Pubitemid 32751617)
16. H.F. Yuen, Y.P. Chan, K.K. Chan Id-1 and Id-2 are markers for metastasis and prognosis in oesophageal squamous cell carcinoma Br J Cancer 97 2007 1409 1415
17. J. Kononen, L. Bubendorf, A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847 (Pubitemid 28331029)
18. O. Straume, L.A. Akslen Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanoma Br J Cancer 93 2005 933 938 (Pubitemid 41487020)
19. C. Gomez-Roca, C.M. Raynaud, F. Penault-Llorca Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites J Thorac Oncol 4 2009 1212 1220
20. I. Zlobec, R. Steele, L. Terracciano, J.R. Jass, A. Lugli Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer J Clin Pathol 60 2007 1112 1116 (Pubitemid 47612643)
21. Z.H. Zhu, B.Y. Sun, Y. Ma Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer J Clin Oncol 27 2009 1091 1099
22. D. Lyden, A.Z. Young, D. Zagzag Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts Nature 401 1999 670 677
23. C.Q. Lin, J. Singh, K. Murata A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells Cancer Res 60 2000 1332 1340 (Pubitemid 30152003)
24. B. Li, P.Y. Cheung, X. Wang Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells Carcinogenesis 28 2007 2313 2320 (Pubitemid 350111589)
25. B. Li, S.W. Tsao, Y.Y. Li Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway Int J Cancer 125 2009 2576 2585
26. J. Liu, Y. Hu, W. Hu, X. Xie, A. Ela Bella, J. Fu Expression and prognostic relevance of Id1 in stage III esophageal squamous cell carcinoma Cancer Biomark 8 2010 67 72
27. Z.R. Zhao, Z.Y. Zhang, H. Zhang, L. Jiang, M.W. Wang, X.F. Sun Overexpression of Id-1 protein is a marker in colorectal cancer progression Oncol Rep 19 2008 419 424 (Pubitemid 351176103)
28. Z. Dong, S. Liu, C. Zhou Overexpression of Id-1 is associated with tumor angiogenesis and poor clinical outcome in oral squamous cell carcinoma Oral Oncol 46 2010 154 157
29. R. Ding, S. Han, Y. Lu Overexpressed Id-1 is associated with patient prognosis and HBx expression in hepatitis B virus-related hepatocellular carcinoma Cancer Biol Ther 10 2010 299 307
30. M. Iwatsuki, T. Fukagawa, K. Mimori Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis Br J Cancer 100 2009 1937 1942
31. S.C. Malaisrie, B. Untch, G.V. Aranha, N. Mohideen, A. Hantel, J. Pickleman Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution Arch Surg 139 2004 532 539 (Pubitemid 38585753)
32. K.A. Kesler, P.R. Helft, E.A. Werner A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone Ann Thorac Surg 79 2005 1116 1121 (Pubitemid 40431824)
33. V. Gebski, B. Burmeister, B.M. Smithers Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis Lancet Oncol 8 2007 226 234 (Pubitemid 46291702)
34. M.F. Catalano, E. Alcocer, A. Chak Evaluation of metastatic celiac axis lymph nodes in patients with esophageal carcinoma: accuracy of EUS Gastrointest Endosc 50 1999 352 356 (Pubitemid 29418820)
35. M.A. Eloubeidi, M.B. Wallace, C.E. Reed The utility of EUS and EUS-guided fine needle aspiration in detecting celiac lymph node metastasis in patients with esophageal cancer: a single-center experience Gastrointest Endosc 54 2001 714 719 (Pubitemid 33668678)
36. M. Okada, T. Murakami, S. Kumano Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer Ann Nucl Med 23 2009 73 80
37. M. Schindl, S.F. Schoppmann, T. Strbel Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors Clin Cancer Res 9 2003 779 785 (Pubitemid 36182615)